Patent: 5,075,222
✉ Email this page to a colleague
Summary for Patent: 5,075,222
Title: | Interleukin-1 inhibitors |
Abstract: | DNA sequences that encode Interleukin-1 inhibitors and recombinant-DNA methods for the production of interleukin-1 inhibitors are provided. The DNA sequences encode proteins having interleukin-1 inhibitors activity. |
Inventor(s): | Hannum; Charles H. (Boulder, CO), Eisenburg; Stephen P. (Boulder, CO), Thompson; Robert C. (Boulder, CO), Arend; William P. (Denver, CO), Joslin; Fenneke G. (Denver, CO) |
Assignee: | Synergen, Inc. (Boulder, CO) |
Application Number: | 07/506,522 |
Patent Claims: | see list of patent claims |
Details for Patent 5,075,222
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Swedish Orphan Biovitrum Ab (publ) | KINERET | anakinra | Injection | 103950 | November 14, 2001 | ⤷ Sign Up | 2008-12-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,075,222
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 911981 | ⤷ Sign Up |
South Africa | 905593 | ⤷ Sign Up |
South Africa | 894052 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9534326 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9216221 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 8911540 | ⤷ Sign Up |
United States of America | 6858409 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |